JINGJING SUN

EDUCATION

2007-2012: Ph.D., Quantitative Systems Pharmacology

· Thomas J. Long School of Pharmacy and Health Sciences, University of the Pacific, CA，USA

2002-2005:  M.S., Pharmacokinetics

· Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, P. R. China

1998-2002:  B.S., Pharmacy

China Pharmaceutical University, P. R. China

RELATED PROFESSIONAL EXPERIENCE

2024-current:Principal Investigator, Director of the Bioassessment Platform, Center for Innovative Drug Development, Great Bay Area Institute of Precision Medicine(Guangzhou)

2013-2024: Guangzhou General Pharmaceutical Research Institute, P. R. China

2020-2024: Head of Research Project Management Integrated Platform

Guangzhou Pharmaceutical Holdings Limited (GPHL)

2019-2024: Director of Drug Research and development Department in Guangzhou General Pharmaceutical Research Institute

2018-2021: Director of Biological samples analysis center in Guangzhou General Pharmaceutical Research Institute

2013-2020: Vice Director of Key Drug safety evaluation GLP center in Guangzhou General Pharmaceutical Research Institute

2011-2012:  Researcher,Genentech, San Francisco, CA,USA

2007-2011: Teaching Assistant,Thomas J. Long School of Pharmacy and Health Sciences, University of the Pacific, CA,USA

2005-2007:  Scientist, Guangdong Institution for Drug Control, P. R. China

MEMBERSHIPS

Ad hoc Specialist of AAALAC international

Committee member of Chinese Society of Toxicology（CST）

Committee member of Guangdong-hong kong-macau Bay Area Administration in urgent need of importing Hong Kong-Macao drug and medical device

Member of a council of Guangdong pharmacology Society